TY - JOUR
T1 - Re
T2 - Disregarding the impact of nicotine on the developing brain when evaluating costs and benefits of noncombustible nicotine products
AU - Abrams, David B.
AU - Glasser, Allison M.
AU - Villanti, Andrea C.
AU - Pearson, Jennifer L.
AU - Rose, Shyanika
AU - Niaura, Raymond S.
N1 - Publisher Copyright:
© 2019 Elsevier Inc.
PY - 2019/3
Y1 - 2019/3
N2 - This Letter to the Editor is in response to a letter from Ms. Flannery, titled, “Disregarding the impact of nicotine on the developing brain when evaluating costs and benefits of noncombustible nicotine products”. In our response, we address some concerns raised by Ms. Flannery, and reiterate our position in our original article. In particular, we underline the importance of a rational public health calculus that weighs beneficial and harmful consequences of policies related to noncombustible nicotine product (NNP) use. We further emphasize the need to correct misperceptions about relative risk of different products to encourage smokers to switch to NNPs. Lastly, we are explicit about our assertion that no use of any nicotine-containing products is the only way to avoid harm at any age, but that we must view this issue pragmatically for the benefit of public health.
AB - This Letter to the Editor is in response to a letter from Ms. Flannery, titled, “Disregarding the impact of nicotine on the developing brain when evaluating costs and benefits of noncombustible nicotine products”. In our response, we address some concerns raised by Ms. Flannery, and reiterate our position in our original article. In particular, we underline the importance of a rational public health calculus that weighs beneficial and harmful consequences of policies related to noncombustible nicotine product (NNP) use. We further emphasize the need to correct misperceptions about relative risk of different products to encourage smokers to switch to NNPs. Lastly, we are explicit about our assertion that no use of any nicotine-containing products is the only way to avoid harm at any age, but that we must view this issue pragmatically for the benefit of public health.
KW - Harm reduction
KW - Tobacco control
KW - e-Cigarettes
UR - http://www.scopus.com/inward/record.url?scp=85061097741&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85061097741&partnerID=8YFLogxK
U2 - 10.1016/j.ypmed.2018.12.027
DO - 10.1016/j.ypmed.2018.12.027
M3 - Letter
C2 - 30738502
AN - SCOPUS:85061097741
SN - 0091-7435
VL - 120
SP - 158
EP - 159
JO - Preventive Medicine
JF - Preventive Medicine
ER -